0001839882-23-006255.txt : 20230308 0001839882-23-006255.hdr.sgml : 20230308 20230308161201 ACCESSION NUMBER: 0001839882-23-006255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230308 DATE AS OF CHANGE: 20230308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUGGAN ROBERT W CENTRAL INDEX KEY: 0001055919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 23716255 MAIL ADDRESS: STREET 1: 611 SOUTH FORT HARRISON AVE STREET 2: SUITE 306 CITY: CLEARWATER STATE: FL ZIP: 33756 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2882 SAND HILL ROAD STREET 2: SUITE 106 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: 2882 SAND HILL ROAD STREET 2: SUITE 106 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 dugganform4_030623.xml FORM 4 X0306 4 2023-03-06 0 0001599298 Summit Therapeutics Inc. SMMT 0001055919 DUGGAN ROBERT W 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756 1 1 0 0 Chief Executive Officer Common Stock 2023-03-06 4 P 0 376489880 1.05 A 552354161 D Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering. /s/ Robert W. Duggan 2023-03-08